GSK to pay $1 billion for exclusive license to J&J’s hepatitis B therapy
(Reuters) -GSK will pay about $1 billion for exclusive rights to further develop and commercialize Johnson & Johnson’s hepatitis B…
Nvidia shares drop after report of canceled China orders
By Chibuike Oguh NEW YORK (Reuters) -Shares of Nvidia Corp dropped by about 5% to a near five-month low on…
BP shares slump as Q3 profit misses forecast on weak gas
By Ron Bousso and Shadia Nasralla LONDON (Reuters) – BP on Tuesday reported third-quarter earnings of $3.3 billion, missing analysts’…
Amgen sales rise, but shares off as investors await obesity data
By Deena Beasley (Reuters) -Amgen on Tuesday said third-quarter sales rose 5%, but a full-year sales forecast raise only reflected…
Apple revamps Mac lineup and pricing with new family of chips
By Stephen Nellis SAN FRANCISCO (Reuters) -Apple on Monday introduced new MacBook Pro and iMac computers and three new chips…
Biden administration aims to cut AI risks with executive order
By Jeff Mason, Trevor Hunnicutt and Alexandra Alper (Reuters) -U.S. President Joe Biden is seeking to reduce the risks that…
Lower prices, oversupply to weigh on lithium miners
By Arunima Kumar (Reuters) – Albemarle Corp, the world’s largest producer of lithium, is expected to report lower quarterly profit…
Exclusive-G7 to agree AI code of conduct for companies -G7 document
By Foo Yun Chee BRUSSELS (Reuters) -The Group of Seven industrial countries will on Monday agree a code of conduct…
China’s foreign minister suggests road to Xi-Biden summit will not be smooth
BEIJING (Reuters) -China’s Foreign Minister Wang Yi said the “road to the San Francisco summit will not be a smooth…
Investors on edge as Middle East conflict intensifies
By Lewis Krauskopf NEW YORK (Reuters) -Investors are watching for signs that the conflict in the Middle East may be…